Texas Retina Associates First in U.S. to Dose a Patient in the Phase 2 SIGLEC Trial
On June 1, 2023, Ashkan Abbey, MD, dosed the first patient in the Phase II SIGLEC Trial, a clinical study evaluating AVD-104, a potential new treatment for geographic atrophy (GA) from age-related
read more
Dr. Abbey Presents Phase 1 DAVIO Clinical Trial Results to the Association for Research in Vision and Ophthalmology
Dr. Abbey presented the results from the Phase 1 DAVIO trial at ARVO 2023, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO). The trial was a first-in-human
read more
Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration
The TRUCKEE study is a real-world, collaborative effort to investigate the efficacy, durability, and safety of a monoclonal antibody treatment called faricimab in patients suffering from neovascular age-related macular degeneration (nAMD) in
read more
Dr. Wang Participated in Roundtable Discussion on XIPERE Treatment for Macular Edema Associated with Uveitis
At the most recent American Academy of Ophthalmology (AAO) Annual Meeting in Chicago, Texas Retina Associates’ Robert Wang, MD, participated in a roundtable discussion with seven other retina specialists to share their
read more
Getting to Know Ocular Oncologist Timothy S. Fuller, MD
May is Ocular Melanoma Awareness Month. Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina Associates,
read more
New Clinical Trials Available
At Texas Retina Associates, our physicians remain actively involved in conducting research that will improve care for our patients, offering access to promising new retinal treatments through clinical trials. We recently opened
read more
May is Ocular Melanoma Awareness Month
Although rare, ocular (uveal) melanoma is the most common primary cancer of the eye in adults with an estimated 2,000 – 3,000 new cases in the United States each year. This type
read more
May is Healthy Vision Month: Take These 10 Steps to Protect Your Eyes
The National Eye Institute has designated May as Healthy Vision Month. It is the perfect time to learn how to protect your eyes and vision, and to encourage your family members to
read more Dr. Abbey Featured in Retina Times
Texas Retina Associates’ Ashkan Abbey, MD, was featured in the “5 Questions” segment of the latest issue of Retina Today. In the article, he discusses his passion for retina research, what led
read more
What You Should Bring to Your Appointment
Our team at Texas Retina Associates works hard to provide you with personalized, comprehensive care, including an accurate diagnosis and access to the latest treatment options for your condition. To help us,
read more